Literature DB >> 10843900

Identification of ecto-PKC on surface of human platelets: role in maintenance of latent fibrinogen receptors.

A Babinska1, M V Hogan, T Sobocki, M B Sobocka, Y H Ehrlich, E Kornecki.   

Abstract

Human platelets express a protein phosphorylation system on their surface. A specific protein kinase C (PKC) antibody, monoclonal antibody (MAb) 1.9, which binds to the catalytic domain of PKC and inhibits its activity, causes the aggregation of intact platelets while inhibiting the phosphorylation of platelet surface proteins. Photoaffinity labeling with 100 nM 8-azido-[alpha(32)P]ATP identified this ecto-PKC as a single surface protein of 43 kDa sensitive to proteolysis by extracellular 0.0005% trypsin. Inhibition of the binding of 8-azido-[alpha(32)P]ATP to the 43-kDa surface protein by MAb 1.9 identified this site as the active domain of ecto-PKC. Covalent binding of the azido-ATP molecule to the 43-kDa surface protein inhibited the phosphorylative activity of the platelet ecto-PKC. Furthermore, PKC pseudosubstrate inhibitory peptides directly induced the aggregation of platelets and inhibited azido-ATP binding to the 43-kDa protein. Platelet aggregation induced by MAb 1.9 and by PKC inhibitory peptides required the presence of fibrinogen and resulted in an increase in the level of intracellular free calcium concentration. This increase in intracellular free calcium concentration induced by MAb 1.9 was found to be dependent on the binding of fibrinogen to activated GPIIb/IIIa integrins, suggesting that MAb 1.9 causes Ca(2+) flux through the fibrinogen receptor complex. We conclude that a decrease in the state of phosphorylation of platelet surface proteins caused by inhibition of ecto-PKC results in membrane rearrangements that can induce the activation of latent fibrinogen receptors, leading to platelet aggregation. Accordingly, the maintenance of a physiological steady state of phosphorylation of proteins on the platelet surface by ecto-PKC activity appears to be one of the homeostatic mechanisms that maintain fibrinogen receptors of circulating platelets in a latent state that cannot bind fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843900     DOI: 10.1152/ajpheart.2000.278.6.H2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

1.  An insight into the sialome of the oriental rat flea, Xenopsylla cheopis (Rots).

Authors:  John F Andersen; B Joseph Hinnebusch; David A Lucas; Thomas P Conrads; Timothy D Veenstra; Van M Pham; José M C Ribeiro
Journal:  BMC Genomics       Date:  2007-04-16       Impact factor: 3.969

Review 2.  Ectokinases as novel cancer markers and drug targets in cancer therapy.

Authors:  Garif Yalak; Viola Vogel
Journal:  Cancer Med       Date:  2014-12-14       Impact factor: 4.452

Review 3.  Proteomic database mining opens up avenues utilizing extracellular protein phosphorylation for novel therapeutic applications.

Authors:  Garif Yalak; Bjorn R Olsen
Journal:  J Transl Med       Date:  2015-04-19       Impact factor: 5.531

4.  Ecto-protein kinases and phosphatases: an emerging field for translational medicine.

Authors:  Garif Yalak; Yigal H Ehrlich; Bjorn R Olsen
Journal:  J Transl Med       Date:  2014-06-12       Impact factor: 5.531

5.  Infectivity of Leishmania mexicana is associated with differential expression of protein kinase C-like triggered during a cell-cell contact.

Authors:  Nidia Alvarez-Rueda; Marlène Biron; Patrice Le Pape
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.